Moreover, TMP21 inhibits mTOR- and PKCδ-mediated apoptosis in cancer cells, while dysfunction of mTOR- and PKCδ is implicated in synaptic impairment and neuronal apoptosis (Caccamo et al., 2010; Wang et al., 2011; Xu et al., 2015). Here, PRKCD is linked to cancer.